Trials / Recruiting
RecruitingNCT05916287
FAMILY INHERITANCE, GENE-GENE AND GENE-ENVIRONMENT INTERACTIONS IN THE FIELD OF CARDIOVASCULAR AND RENAL DISEASES. Fifth Visit of the STANISLAS Cohort
HÉRITABILITÉ FAMILIALE, INTERACTIONS GÈNE-GÈNE ET GÈNE-ENVIRONNEMENT DANS LE DOMAINE DES MALADIES CARDIOVASCULAIRES ET RENALES. Cinquième Visite de la Cohorte STANISLAS
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,000 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The Stanislas Cohort is a monocentric familial longitudinal cohort originally comprised of 1006 families consisting of two parents and at least two biological children and deemed healthy, recruited in 1993-1995 at the Centre for Preventive Medicine of Nancy. This cohort was established with the primary objective of investigating gene-gene and gene-environment interactions in the field of cardiovascular diseases. The 5th visit of the STANISLAS Cohort will allow a better evaluation of the cardiovascular ageing of the population and the transition toward cardiovascular or renal diseases in relation with their genetic profile and environment.
Detailed description
The main objective of the STANISLAS cohort is to identify the factors associated with cardiovascular aging (assessed through the study of the degradation of morphological and functional parameters of the heart and vascular systems). Data (clinical, biological, morphological, genetic and lifestyle) from previous visits (the first having been initiated in the mid-1990s) will be considered as exposure and / or adjustment variables. The exposure variables of interest will be: * The components of metabolic syndrome (MS), * Genetic determinants, through an approach of family segregation and candidate genes, * Multi-omic biomarkers analyzed from the biological collection of the first assessments of the cohort * Food intake, nutrition and eating behavior The secondary objectives are * Identify the factors associated with a degradation of renal parameters (renal function and proteinuria). * Identify the factors associated with a degradation of metabolic parameters. * To assess the association between SARS-CoV-2 infection (questionnaire and serological approach) and cardiovascular and renal parameters * Identify factors associated with the occurrence of clinical cardiovascular events. * Association between Covid 19 events and general disabling symptoms * Complete the cohort's biological collection for future biomarker assays related to previous objectives
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood and urine samples | Blood and urine samples |
| GENETIC | Blood samples | Blood samples |
| OTHER | Cardiovascular assessment | Echocardiography, Lung ultrasound, pulse wave velocity, carotid stiffness and thickness, Central and peripheral blood pressure, carotid pulse pressure, abdominal aorta ultrasound, jugular vein ultrasound, liver elastography (Optional). |
| BEHAVIORAL | Dietary intake | Food frequency questionnaires, ''Dutch eating behaviour questionnaire'' and dietary supplement questionnaire |
| OTHER | Anthropometric parameters | Measurement of height, weight, abdominal circumference, hip circumference, arm circumference |
| OTHER | Hemodynamic parameters | Systolic pressure index measurement |
| OTHER | Hemodynamic parameters | Heart rate measurements, blood pressure measurements, orthostatic BP measurements |
| OTHER | Hemodynamic parameters | Blood pressure measurements by "unattended BP" monitor over 5 min |
| OTHER | Hemodynamic parameters | Electrocardiogram |
| BEHAVIORAL | Assessment of compliance with antihypertensive treatments for treated participants | EVALOBS scale and compliance questionnaire |
| OTHER | Ambulatory 24 hours measurment of blood pressure | For the first 100 patients willing to participate |
| BIOLOGICAL | 24 hours urinary collection | For the first 100 patients willing to participate. For biobank constitution and measurement of microalbuminuria, creatininuria, osmolarity, natriuresis, kaliuresis, urea, proteinuria and urine dipstick |
| OTHER | General questionnaires | Collection of socio-demographic data such as age, level of education, profession, household income, smoking status, physical activity, perception of health, prematurity, height and weight at birth, family and personal history especially cardiovascular (history of stroke, myocardial infarction, heart failure, current pathologies, drugs, tobacco...) |
| OTHER | Women specific questionnaire | Women specific questionnaire |
| BEHAVIORAL | Women specific questionnaire | Women specific questionnaire |
| DIAGNOSTIC_TEST | NYHA dyspnea questionnaire | Determination of NYHA class. |
| BEHAVIORAL | Anxiety questionnaire | Assessment of anxiety |
| BEHAVIORAL | Epworth Sleepiness Scale | sleep quality assessment |
| OTHER | A questionnaire on the "perception of the management of cardiovascular risk factors" | Patient's evaluation of cardiovascular risk factors by the health system |
| BEHAVIORAL | A questionnaire on eating behaviors | Assessment of eating behaviors |
| BEHAVIORAL | A questionnaire on eating habits to determine consumer profiles | Assessement of eating habit to create a consumer profile |
| DIETARY_SUPPLEMENT | A questionnaire on food supplements use | Evaluation od food supplements intake |
| OTHER | SARS-CoV-2 Infection Questionnaire | SARS-CoV-2 Infection Questionnaire |
| OTHER | Instantaneous expired air analysis | Carbon monoxyde analysis in expired air |
| BIOLOGICAL | Capillary sampling | Capillary sampling for pollutant analysis (Optional) |
Timeline
- Start date
- 2023-07-13
- Primary completion
- 2027-07-13
- Completion
- 2027-07-13
- First posted
- 2023-06-23
- Last updated
- 2023-08-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05916287. Inclusion in this directory is not an endorsement.